On Oct. 18, 2024, the California Department of Public Health (CDPH) reported that a total of 13 human…
On Oct. 10, 2024, Genentech announced today that the U.S. Food and Drug Administration (FDA) approved ItovebiTM (inavolisib),…
On Oct. 6, 2024, San Diego County officials announced they were investigating the first ever case of locally…
On Oct. 3, 2024, the California Department of Public Health (CDPH) reported that the human case previously under…
On Sept. 20, 2024, a research team led by scientists at the University of California, Riverside, announced they…
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
On Aug. 30, 2024, the California Institute for Regenerative Medicine (CIRM) approved $67.5 million to support five projects…
On Aug. 13, 2024, President Joe Biden announced $150 million in awards from the Advanced Research Projects Agency…
On Aug. 8, 2024, scientists at UC San Diego’s Scripps Institution of Oceanography announced they had discovered the…
On May 29, 2024, 23andMe with support from The Michael J. Fox Foundation for Parkinson’s Research, announced it…
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
On Jan. 22, 2024, the University of California, Davis announced the first reported outbreak of high pathogenicity H5N1…
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
On Nov. 27, 2023, University of Wisconsin-Madison researchers released a study that showed COVID-19 caused an alarming surge…
On Oct. 30, 2023, the California Department of Public Health (CDPH) reported the first locally acquired case of…
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…
On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…
On Sept. 29, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $43.8 million to fund projects aimed…
On Sept. 25, 2023, researchers at the University of California, Berkeley reported that engineered viruses also can generate…
On Aug. 27, 2003, The Institute for Collaborative Biotechnologies (ICB) announced it was funding a $50 million five…
On Aug. 24, 2023, NIAID reported that emerging resistance to common malaria treatments in Uganda could be connected…
On Aug. 24, 2023, researchers at City of Hope announced were awarded $32.3 million from the California Institute…
On Aug. 23. 2023, researchers co-led by University of California, Santa Cruz Assistant Professor of Biomolecular Engineering Karen…
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
On Mar. 27. 2023, Thermo Fisher Scientific and the University of California, San Francisco, announced they will accelerate…
On Dec. 24, 2022, the U.S. Food and Drug Administration (FDA) approved updated labeling for Genentech’s capecitabine tablets…
On Dec. 9, 2022, the U.S. Food and Drug Administration (FDA) approved Genentech’s atezolizumab (Tecentriq) for adult and…
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…